 2. Patients with persistent dyspnea, defined in this study as dyspnea at rest with an average intensity level 3 out of a Numeric Rating Scale from 0 to 10 for at least 2 week and just prior to study initiation, despite supplemental oxygen of up to 21 Lmin to keep oxygen saturation 90 